Navigation Links
Cephalon Quarterly Conference Call Invitation
Date:6/26/2008

Second Quarter 2008 Earnings Conference Call Tuesday, July 29, 2008, 5:00

p.m. U.S. EDT

FRAZER, Pa., June 26 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) has scheduled its regular quarterly earnings conference call covering second quarter 2008 results for 5:00 p.m. EDT on Tuesday, July 29, 2008.

July 29, 2008 Schedule

4:10 p.m. EDT Q2 2008 results will be distributed by PRNewswire

4:50 p.m. EDT To participate in the conference call, dial 913-312-9303 and refer to Conference Code Number 6640353

5:00 p.m. EDT Conference call begins promptly.

Simultaneous Webcast

Investors can listen to the call live by logging on to the company's website at http://www.cephalon.com and clicking on "Investor Information" then "Webcast." Please click on the link and follow the prompts for registration and access.

If you are unable to listen to the live broadcast, an audio or webcast replay of the call will be available approximately two hours after the event until Midnight EDT, August 12, 2008. To listen to the audio replay, dial 719-457-0820 and use the Conference Code Number 6640353.

Additional information presented on the conference call may be made available on the Investor Information page of the company's website.


'/>"/>
SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
3. Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
4. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
5. Cephalon Quarterly Conference Call Invitation
6. Cephalon Announces Strong Third Quarter Financial Results
7. Cephalon Submits Supplemental New Drug Application for FENTORA
8. Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkins Lymphoma
9. Cephalon Presentation Slides for the 26th Annual JPMorgan Healthcare Conference Now Available
10. Cephalons EFFENTORA Receives Positive Opinion from European Regulatory Authorities for the Management of Breakthrough Cancer Pain
11. Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008).../ -- Cell Therapeutics, Inc. ("CTI",or the "Compa... single,institutional investor shall purchase, fo...nior Notes due 2011 (the "Notes"), with a conversi...tes would have a $32.65 million initial principal ...ing the holder, upon any conversion of,the Notes,...
(Date:12/4/2008)... 4 Octapharma,Chairman Wolfgang M... been,selected to lead Octapharma,s plasma operat...arma,s U.S. legal counsel since 2002 and will now ... The largest private plasma products company ...herapeutics, the Atlanta company that operates 12,...
(Date:12/4/2008)...-FirstCall/ -- Raymond J. De Hont, Chairman and Ch...: MPR ), announced today that the Company,s Board...8, declared a quarterly dividend of $0.06 per shar...ord at the close of business on February 26, 2009....e same period last year. , , This is the th...
(Date:12/4/2008)...me Onrigin(TM) for Laromustine , , NEW HAVE...HARMACEUTICALS, INC. (OTC Bulletin Board: VION) t...in connection with the 50th American Society of He...an Francisco from December 6-9, 2008. , , ...ny announced that it would present survival data f...
Breaking Biology Technology:Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $32.65 Million of Senior Convertible Notes 2Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $32.65 Million of Senior Convertible Notes 3Octapharma Names Dennis D. Curtin To Lead U.S. Plasma Operations 2Met-Pro Corporation Declares Quarterly Dividend 2Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 2Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 3Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 4
...rry Landweber, who was involved in one of the firs...s expertise on the next stage of the Internet, whi...ation. , ,The Computer & Information Science & En...Foundation has proposed a research project that m... ,The Global Environment for Networking Investigat...
...tics has selected RedPrairie Corp.,s DLx Labor W...productivity and customer service throughout its d...day. DCS Logistics , with corporate offices in De... solution at all of its logistics centers. , ,DSC...anies such as Kellogg,s, Unilever, Yamaha, Georgia...
...sin businesses each will receive $15,000 in fundin...te Department of Commerce, Gov. Jim Doyle announce... the Technology Assistance Grant to hire professio... business commercialization planning. The company,...physicians with tools and information to apply bes...
...ntative measures, Katrina caught many businesses a...fessor James Carlini, what disaster recovery plans... your home and how updated are they? , ,While mos...nd residential aspects, few reports have really ta...nesses down in the South. , ,They already have sai...
Other Biology Technology:Madison professor emeritus will consult on development of 'Internet 2' 2Madison professor emeritus will consult on development of 'Internet 2' 3Hurricane Katrina: Many disaster recovery systems were outdated 2Hurricane Katrina: Many disaster recovery systems were outdated 3Hurricane Katrina: Many disaster recovery systems were outdated 4
(Date:12/4/2008)...en touting their intelligence and their high incom...sity and Oxford University that studied 400 lonely...rs. , Research in the theory of evolution includ... women choose their partners. Among the more esta...tractive appearance, whereas resources and social ...
(Date:12/4/2008)...y Springer as of January 2009. The official journa...eviously published by Wiley-Blackwell, is respecte... applied research articles in a broad range of sub...lished in English six times a year, Fisheries Sci...ng a wide array of topics in both marine and fresh...
(Date:12/3/2008)...ctor of the International Energy Agency, will pres... University,s Baker Institute for Public Policy. ,...rld facing a supply crunch because of geology or i...cy framework might stabilize greenhouse gases at l...h a policy framework have on future energy choices...
(Date:12/3/2008)...ice this week. The most exciting new film features...entists using ground-breaking technology. , For...,s Centenary Institute have filmed an immune cell ...nfection as it begins to spread throughout the bod...mmune Imaging program at the Centenary Institute, ...
Breaking Biology News(10 mins):Myth about 'dirty old men' supported by science 2'World Energy Outlook' to be presented at Rice University Dec. 9 2Scientists film inner workings of the immune system 2Mesa Labs to Participate in the Health Care Trade Policy Mission in Beijing on April 23 25 2008 17182 1BioDuro 26 The National Center for Safety Evaluation of Drugs Received Full AAALAC Accreditation 4699 1BioDuro 26 The National Center for Safety Evaluation of Drugs Received Full AAALAC Accreditation 4699 2Breast cancers behave differently before and after the age of 70 2954 1Breast cancers behave differently before and after the age of 70 2954 2Breast cancers behave differently before and after the age of 70 2954 3Mammograms benefit women up to the age of 75 and 3 yearly screening intervals are best 17177 1Mammograms benefit women up to the age of 75 and 3 yearly screening intervals are best 17177 2Mammograms benefit women up to the age of 75 and 3 yearly screening intervals are best 17177 3
...l responsible for promoting the type of immune res...t the type of inflammation associated with debilit...thritis and multiple sclerosis, according to resea...of Veterinary Medicine. The researchers discovere...ne, both prevents destructive inflammation and pro...
... issue of the journal Genome Research , two teams... the human genome called transcription-induced chi...ingle, fused RNA transcript. The work has implica...anding mechanisms underlying gene evolution, trans...r. Roderic Guigó,s group from the Centre de Regula...
... is pleased to announce the launch of Biology Dire...system of peer review. Biology Direct will operate...ewers, reports published alongside each article. T...ring that the author approach Biology Direct Edito...pt. , The journal, available online at www.biolog...
... of Excellence for Integrative Legume Research (CI...ompounds to treat cancer. , CILR researchers scre... from soil bacteria in their roots) for biological...s which could potentially prevent the formation of...ood supply tumours stop growing and ultimately can...
Other Biology News:A Jekyll and Hyde of cytokines: IL-25 both promotes and limits inflammatory diseases 2Tandem transcripts team together 2BioMed Central launches Biology Direct 2BioMed Central launches Biology Direct 3Legume compounds may help cancer treatment 2
...gn , Customer Peptide Synthesis , Containing on...ve 90%, 20 mg will be returned to customer conjuga... , Maintenance 102 days/each , Pre-immune ble...5 /each , Test bleed (app. 5 ml) x1 /each , ...
Mouse Serum • Mouse serum is collected off the clot fasted non-Swiss Albino mice of mixed sex and 8-12 weeks of age. Available Anticoagulants: N-02: Citrate N-04: Heparin (Na) N-06: K2ED
10% Normal Goat Serum from Invitrogen
Human ICAT Affinity Purified Polyclonal Ab
Biology Products: